New Gastric & Esophageal Cancer Treatment Breakthrough

There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.

Frontiers Case Report: Clinical application of continuous

Gastric Cancer Diagnostic Market Statistics, Forecast- 2032

Gastric Cancer Foundation In breakthrough, Japanese researchers

Frontiers Cost-Effectiveness of Nivolumab Plus Chemotherapy vs. Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophagel Adenocarcinoma in China

Recent advances in immune therapies for gastric cancer

Esophageal Cancer Action Network - Esophageal Cancer Action Network

Signaling pathways and therapeutic interventions in gastric cancer

Signaling pathways and therapeutic interventions in gastric cancer

A New Targeted Treatment Shows Promise for Select Patients with